Zumutor Biologics
PrivateLast Round
Series B
Jun 15, 2026
Est. Valuation
$36.2M
Total Funding Raised
$41.2M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Zumutor Biologics is a biotechnology company that develops targeted NK cell therapeutics and high-diversity human antibody libraries to discover innovative immunotherapies for cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Zumutor Biologics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Zumutor Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 15, 2026 | ||||
| Series B | Jun 15, 2024 | ||||
| Series A Extension | Dec 10, 2021 | ||||
| Grant | Sep 7, 2020 | ||||
| Series A Extension | Nov 1, 2019 | ||||
VC Round | Apr 1, 2018 |
Zumutor Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Karnataka Information Technology Venture Fund | Series A, Seed |
| Bharat Innovation Fund | Series A Extension, Series B |
| Aarin Capital Partners | Series A, Seed |
| Premji Invest | Series B |
| Siana Capital Management | Series A Extension |
| Chiratae Ventures | Series A, Seed |
| Accel | Series A Extension, Series A, Seed, Series B, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 15, 2026
$7.3M raised led by Accel and Bharat Innovation Fund.
- Sep 7, 2020
Received grant funding to support operations.
Zumutor Biologics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Zumutor Biologics's valuation, stock price, and market status.